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e90 Letterswas deemed multisystem organ failure caused
by complications of acute generalized exanthema-
tous pustulosis (AGEP) without internal sources of
sepsis.
We present a case of atypical AGEP with severe
mucocutaneous involvement that resulted in death.
On initial evaluation, the differential diagnosis was
primarily TEN and AGEP. A pathological role for
S aureus was not established, as the cultures
were consistent with contamination. Furthermore,
the temporal relationship of the eruption to the
initiation of antibiotics was strongly suggestive of
a drug reaction. Therefore, the diagnostic consider-
ations in this case were TEN, AGEP, or an overlap
syndrome of the two. In this patient, although a few
pustules were present initially, the overwhelming
amount of epidermal detachment and mucosal
involvement clinically favored TEN. However,
with the histopathological findings of subcorneal
pustules without epidermal necrosis, the final
diagnosis was atypical AGEP with severe mucocu-
taneous involvement.
Severe cutaneous adverse reactions include TEN,
AGEP, and drug reaction with eosinophilia and
systemic symptoms, which vary in their presenta-
tion and prognosis.1,2 Because of the potential
clinical overlap in these severe cutaneous adverse
reactions, AGEP should be considered in the
differential diagnosis of generalized desquamation.
However, the expected clinical course and
prognosis may vary from what is typically seen.3-5
We herein report a case of fulminant AGEP with
severe mucocutaneous involvement that resulted in
death and highlight the potential for high mortality
in this setting.
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Peripheral facial palsy after topical
photodynamic therapy for facial actinic
keratoses
To the Editor: A 64-year-old man presented with
multiple actinic keratoses (AK) in sun-exposed skin.
Previous treatments included cryotherapy and a
single treatment with topical photodynamic therapy
(PDT) to frontal AK leading to partial response. We
performed a second treatment with topical methyl-
aminolevulinate (MAL) PDT to AK on the left side of
the forehead, temple, cheek, and jaw. We applied a
total amount of 2 g of MAL cream over a treatment
field of about 120 cm2, which was kept under
occlusive dressing for 3 hours. After this, we irradi-
ated the area with a dose of 37 J/cm2 of red light
(wavelength, 630 nm) and this was well tolerated.
One week after MAL-PDT the patient developed a
complete paralysis of the left hemifacial muscles. He
did not have a history of recent fever, pain, hyper-
acusis, numbness, or loss of sensation around the
affected side ear. The ear, nose, and throat exami-
nation revealed normal findings and no herpetic
vesicles were found. He presented normal results for
brain magnetic resonance imaging and computed
tomography scans. Other secondary causes of pe-
ripheral facial palsy (PFP) such as otitis, mastoiditis,
Lyme disease, Guillain-Barre syndrome, trauma, and
tumors were ruled out, and a working diagnosis of
an idiopathic left PFP was established (Fig 1). We
treated the patient with systemic corticosteroids for 2
weeks without response. Sixteen months after dis-
ease onset, no clinical improvement was observed.
Topical PDT is a nonsurgical treatment approved
for certain superficial nonmelanoma skin cancers
and AK. PDT is generally well tolerated, and themost
frequently reported adverse effect is local pain.1,2 In
our case, we observed a correlation between topical
MAL-PDT and the development of an ipsilateral PFP
after 1 week, which suggests a causal association.
Fig 1. Complete left peripheral facial palsy 1 week after topical photodynamic therapy for left
hemifacial actinic keratoses. Physical examination revealed the disappearance of the left
forehead creases and the left nasolabial fold, and drooping of the mouth left corner and the
lower left eyelid (left). When the patient tried to contract the facial muscles, the Bell sign and
a pronounced lagophthalmos appeared, and no movements (synkinesis) were observed
( grade VI/VI of the HouseeBrackmann facial nerve grading scale) (right).
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geniculate ganglion is thought to be the most com-
mon cause of idiopathic PFP (Bell palsy).3 In our
case the stress, pain, or infection produced by the
PDT could have triggered the viral reactivation. PFP
caused by herpes zoster oticus (Ramsay Hunt syn-
drome) should also be considered in the absence of a
vesicle eruption, ie, zoster sine herpete.4 However,
in our case we did not perform any viral tests to
demonstrate the association between viral infection
and PFP. An alternative explanation is the develop-
ment of paralysis of the superficial facial nerve
branches of the left-side face as a side effect of
MAL-PDT. Recently, 2 cases of iatrogenic PFP after
intracranial PDT for treatment of malignant gliomas
have been published.5 The authors suggest that
energy could pass through thin bones overlying the
photosensitized facial nerve in the intratemporal
portion and induce nerve damage.
Our case is of particular interest, as PFP has not
been previously described in association with PDT.
We present an undocumented case of a 64-year-old
man who developed left PFP 1 week after topical
PDT. Although uncommon, his symptoms may be
considered as a possible complication of PDT,
considering the close relation among the treated
zone, the superficial localization of facial nerve
branches, and the short elapsed time.Franco Gemigniani, MD, Domingo Bodet, MD,
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foliaceus.
Fig 2. Potassium hydroxide scraping fromDemodex follic-
ulitis of antecubital fossa. (Original magnification:350.)Demodicidosis on the arms of a patient with
pemphigus foliaceus
To the Editor: Demodexmites are common commen-
sals of the human pilosebaceous follicle that use
sebum as nourishment.1 They are most frequently
found on the face, where the number of sebaceous
glands is greatest, but they have also been observed
on the ear canal, scalp, neck, back, chest, nipples,
buttocks, and penis.2 To our knowledge, there is
only 1 case report of demodectic mites on the
extremities (legs).2 Here we report a case of demo-
dicidosis on the arms.
A 56-year-old Korean man presented with a
several-day history of multiple pustules localized
on both arms. The lesions were asymptomatic.
Pemphigus foliaceus was diagnosed by skin biopsy
2 years earlier and he had been undergoing various
immunosuppressive treatments such as mycophe-
nolate mofetil (MMF), oral corticosteroid, antihista-
mine, topical corticosteroids, and topical calcineurin
inhibitors in the 2 years since the diagnosis. At the
time of the initial appearance of the arm lesions, the
patient was on 360 mg of MMF and 6 mg of
methylprednisolone intermittently for 2 months.
The lesions seemed to increase in number with oral
intake of MMF and decrease with discontinuation.
Physical examination revealed numerous discrete
2- to 3-mm erythematous follicular papules and
pustules on both antecubital fossae (Fig 1). A potas-
sium hydroxide preparation of scrapings from the
erythematous pustules and scales showed the pres-
ence of many Demodex mites (Fig 2). We diagnosed
this case as a Demodex infestation in a patient with
pemphigus foliaceus. Treatment was successful,
albeit slow, over 3 months, with twice-daily appli-
cations of topical metronidazole and benzene hexa-
chloride to the affected areas. We could not use
ivermectin because it is not available in Korea.
Demodexmites are considered normal skin fauna,
and there is no consensus to what degree the mites
are causative of skin pathology and how they might
contribute to disease.1 In general,Demodexmites are
thought to play a pathogenic role when present in
large numbers or with penetration into the dermis.3
In specific environments such as immunologic
deficiency, they can proliferate and provokecutaneous lesions.4 The patient had previously taken
a variety of immunosuppressive drugs for
pemphigus foliaceus treatment, which could be an
important predisposing factor for an increase in the
number of Demodex mites on unusual sites. One of
the multiple effects of MMF on the immune system is
an inhibition of T-lymphocyte proliferation,5 which
can lead tomite invasion and development of clinical
symptoms.4 Demodicidosis can present in the ex-
tremities. Therefore, demodicidosis should be
included in the differential diagnosis of erythema-
tous or pustular follicular eruptions of the extrem-
ities, particularly in patients with immunodeficiency.
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